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Objectives: Asthma is one of the most common long term medical conditions 
and an important contributor to the burden of illness. People with asthma expe-
rience poor life satisfaction and require a range of health services to manage 
their condition. There is a need to assess the instruments by disease concept and 
interpret the dimension scores. The aim of this systematic review is to assess 
the impact of severe asthma on the quality of life (QoL). MethOds: A system-
atic search was conducted of the relevant published evidence from Embase and 
MEDLINE. Search limits were: articles in English, in human and published since 
year 2005. Retrieved citations were screened by two independent reviewers accord-
ing to inclusion criteria: severe asthma and baseline QoL data either measured 
on generic scale or disease-specific scale. Results: A total 29 studies met the 
inclusion criteria. The majority of studies were observational (14 studies) while 
seven studies had cross-sectional design. The majority of studies were conducted 
in adult population (18 studies) while few studies were conducted in children (5 
studies). Asthma Quality of Life Questionnaire (AQLQ) was the most frequently 
used scale among the included studies, assessed in 13 studies followed by St. 
George’s Respiratory Questionnaire (SGRQ) in six studies. Seven studies reported 
total AQLQ data with mean scores ranging from 3.1-4.8, which reflect poor QoL. 
Across these domains, scores assessed on AQLQ - symptoms and AQLQ - activity 
limitations were lower as compared to AQLQ - emotional function and AQLQ - 
environmental stimuli. Data also suggested that patients with severe asthma have 
rapid deterioration in overall health status as compared to patients with mild-
moderate asthma. cOnclusiOns: Patients with severe asthma had lower total 
QoL scores as assessed through different scales, indicating worse QoL. Symptoms 
and activity limitations are the two main domains that potentially affect the QoL 
in patients with severe asthma.
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Objectives: The objective of this study is to assess the translatability of “distressed” 
and to explore conceptually equivalent alternatives. The term has been observed to 
cause difficulties during translation of Clinical Outcomes Assessments (COAs), thus 
warranting further investigation. MethOds: Using Qualtrics, a web-based survey 
distribution service, a questionnaire was sent to 52 linguists who recently translated 
“distressed” in a questionnaire. They were asked if they faced difficulties in translat-
ing the term, to elaborate on these difficulties if applicable and provide conceptually 
equivalent alternatives. Additionally, cognitive debriefing results of “distressed” were 
analyzed. Results: Out of 52 linguists, 29 responded to the questionnaire. Sixty-
two percent (62%) of respondents (18 /29) stated that “distressed” was difficult to 
translate. Synonyms presented by all sample members show that “distressed” lacks 
conceptual equivalency across languages. The most common synonyms provided 
were “suffering,” “affliction,” and “sorrow,” showing variation in the way respondents 
interpret emotional pain associated with “distress.” Four respondents indicated 
that “distressed” could refer to physical or emotional pain in their language. Two 
respondents reported that their language had multiple terms which correspond 
to “distressed.” Nine languages were available for cognitive debriefing analysis. 
“Distressed” appeared to be problematic for four out of the nine languages. Although 
minimal issues were found with the term during debriefing, some subjects claim the 
term to be ambiguous or inappropriate for use in patient questionnaires, which is 
concordant with linguist feedback. cOnclusiOns: Results show that “distressed” 
can be difficult to translate, due to its ambiguity in describing adverse effects. When 
developing a source item measuring distress, it is recommended that multiple alter-
natives such as “despair,” “mental suffering,” and “anxiety” be measured in lieu of a 
single item on “distress,” as the suggested alternatives can neither be ambiguous nor 
misconstrued.
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Objectives: Health satisfaction may help predict adherence to T2DM self-care 
behaviors, a cornerstone of optimal T2DM management. The CHES-Q was developed 
to assess T2DM-related health satisfaction and knowledge among people living with 
T2DM. Because renal impairment is a frequent complication of T2DM, we aimed to 
better understand the experiences of people with T2DM and comorbid CKD and their 
interpretation of CHES-Q items. MethOds: In-depth interviews were conducted 
with 20 adults with T2DM and CKD (stages 1-5) to explore the content and clarity of 
the 14-item CHES-Q. Each interview included a brief discussion about the partici-
pant’s experiences and impact of T2DM and CKD. Then, participants were asked to 
“think out loud” about their process for answering each item and to identify words 
or concepts that were unclear. Probes were used to obtain additional feedback about 
whether any important concepts were missing. Interview responses were grouped 
and summarized. Results: The mean age of participants was 59 years, half were 
female, 45% were white, and 75% completed at least some college. Fifty-five percent 
had stage 5 CKD, 45% were on dialysis, and 2 had received a kidney transplant. 
Average disease duration was 15 years for T2DM and 7.7 years for CKD. All par-
ticipants found the instructions and items clear and relevant. Items that did not 
specifically refer to T2DM or blood sugar were interpreted by participants as relating 
to their health in general. Concepts reported as missing from the CHES-Q included 
erectile dysfunction, concern with diet, and stress, which were each mentioned by 
1 to 3 participants. cOnclusiOns: Health satisfaction is an important concept to 
consider when developing individualized strategies for managing T2DM because 
it may predict adherence to self-care. The CHES-Q assesses T2DM-related health 
satisfaction and is appropriate for use among people with T2DM and comorbid CKD.
item location range; number of items misfitting): ‘Symptoms’ (-4.75 to 4.56; -3.38 
to 2.17; 3/14); ‘Psychological’ (-4.20 to 4.27; -2.53 to 2.65; 1/5); ‘Limitations’ (-4.50 to 
4.55; -2.75 to 2.69; 3/10). cOnclusiOns: Findings from the post-hoc analyses of the 
proposed revised MSIS-29 and MSWS-12 provide an initial evidence-base for the 
enhancement of their measurement performance in patients with SPMS. Additional 
research is needed to determine the extent of improved scale-to-sample targeting 
and interpretability of the impact of MS.
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Objectives: To assess effects of CZP+MTX vs PBO+MTX on workplace and house-
hold productivity and need for help with daily activities in DMARD-naïve patients 
with severe, active, progressive RA.1 MethOds: Patients in this double-blind ran-
domized study (NCT01519791) were DMARD-naïve with active RA < 1yr diagnosis 
at baseline, fulfilling 2010 ACR/EULAR criteria; ≥ 4 swollen and ≥ 4 tender joints; 
DAS28[ESR]≥ 3.2; CRP≥ 10mg/L and/or ESR≥ 28mm/hr, RF/ACPA positive. Patients 
were randomized 3:1 to CZP (400mg Wks 0,2,4 then 200mg Q2W to Wk52)+MTX 
or PBO+MTX (MTX initiated at 10mg/wk, increased to 25mg/wk by Wk8, maxi-
mum tolerated dose maintained to Wk52). Workplace and household productiv-
ity (Work Productivity Survey [WPS]) were assessed; responses (LOCF imputation) 
compared using a non-parametric bootstrap-t method. Need for assistance was 
summarized descriptively. Results: 660 (CZP+MTX) and 219 (PBO+MTX) patients 
were randomized; 655 vs 213 in the full analysis set (pts with baseline and post-
baseline DAS28[ESR]). Baseline characteristics were balanced between study arms; 
52% employed. CZP+MTX patients reported greater improvements vs PBO+MTX 
in household productivity (household work days missed per month BL vs Wk52: 
PBO+MTX= 10.4 vs 3.0, CZP+MTX= 8.8 vs 1.9; household work days with productivity 
reduced by ≥ 50%/month: PBO+MTX= 10.6 vs 3.0, CZP+MTX= 9.4 vs 2.1; level of arthri-
tis interference with household work productivity/month: PBO+MTX= 6.4 vs 2.5, 
CZP+MTX= 6.0 vs 1.9). CZP+MTX patients also reported lower need for assistance in 
usual activities from a relative/friend. Employed CZP+MTX patients reported reduc-
tions in absenteeism and presenteeism vs PBO+MTX (work days missed/month BL 
vs Wk52: PBO+MTX= 4.0 vs 0.9, CZP+MTX= 4.4 vs 0.6; days with work productivity 
reduced by ≥ 50%/month: PBO+MTX= 8.8 vs 1.8, CZP+MTX= 6.4 vs 1.0; level of arthritis 
interference with work productivity/month: PBO+MTX= 5.8 vs 1.9, CZP+MTX= 5.5 vs 
1.4). cOnclusiOns: In DMARD-naïve patients with severe, active, progressive RA, 
CZP+MTX showed greater improvements at 1-year in workplace and household 
productivity and reduced need for assistance with regular activities vs PBO+MTX. 
1. Emery. Ann Rheum Dis 2015;74(S2):712
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Objectives: To identify common translation issues occurring during linguistic 
validation of depression scales; to assess possible solutions that could be applied 
across target languages. MethOds: We gathered back-translation reviews from 
linguistic validation projects comprising four depression scales and spanning 
thirteen languages; identified issues faced during discussion with lead linguis-
tic validation consultants in-country; compared problems and solutions to find 
any patterns; highlighted challenges common to depression scales. Results: 
There were three main challenges: 1. Colloquial expressions are frequently used. 
Problematic items included ‘I could not get going’ and ‘I could not shake off the 
blues’. All languages reviewed had no colloquial equivalent for ‘shake off the 
blues’; we resolved to create conceptual equivalence (‘I could not get rid of my 
depression’/’I could not stop feeling sad’) with a conversational register to reflect 
the source. 2. Some symptoms of depression are challenging to translate. For 
example, ‘worthless’ and ‘worthwhile’ posed problems for 62% of languages. Most 
often, the terms were confused with ‘useless/useful’. Where there was no direct 
translation, and when suitable for the clinical context, these terms were translated 
as ‘worth nothing’ and ‘valuable’. 3. The marginally-nuanced ideas were no prob-
lem for a broad English vocabulary, however, during linguistic validation, there was 
difficulty differentiating between English source terms such as ‘wound-up’, ‘nerv-
ous’, ‘agitated’, ‘restless’ and ‘tense’. All target languages struggled to translate 
‘nervous’ and ‘wound-up’ in two separate terms. Project managers defined the lat-
ter as ‘brought to a state of great tension’, possibly including ‘nervous movement’, 
and the concept was rendered successfully. cOnclusiOns: Attitudes towards 
depression vary across different cultures. Verbatim translations are found to be 
risky for numerous reasons but, with careful discussion between lead linguists and 
project managers, conceptually-equivalent, culturally-adapted wording is found 
to allow for this. To the issues reviewed, similar solutions were applied across 
languages and in different depression scales.
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